XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 27, 2024
Equity [Abstract]  
Schedule of Allocation of Share-Based Compensation Expense
The following table sets forth the detailed allocation of the share-based compensation expense which was included in the Company’s condensed consolidated statements of operations:
 Three Months EndedNine Months Ended
(in thousands)September 27, 2024September 29, 2023September 27, 2024September 29, 2023
Cost of revenue$295 $606 $1,091 $1,895 
Research and development expense1,804 2,152 5,282 5,982 
Selling, general and administrative expense3,611 4,483 13,214 12,847 
Total$5,710 $7,241 $19,587 $20,724 
Schedule of Restricted Stock Units
(in thousands, except per share amounts)Number
of
Shares
Weighted Average
Grant-Date Fair Value
Per Share
Balance at December 31, 20233,242 $12.42 
Granted3,128 13.22
Vested(1,831)12.07
Forfeited(848)13.96
Balance at September 27, 20243,691 $12.92